Alembic Pharma gets USFDA nod for its antibiotic capsules

Drug firm Alembic Pharmaceuticals today said it has received approval from the US health regulator for its Doxycycline Hyclate capsules used for treatment of wide variety of bacterial infections.

The approval from the United States Food and Drug Administration (USFDA) is for the company’s abbreviated new drug application (ANDA) for Doxycycline Hyclate capsules USP, in the strengths of 50 mg and 100 mg, Alembic Pharmaceuticals said in a filing to BSE.

The product is generic version of Pfizer Inc’s Vibramycin capsules in the same strengths, it added.

“Doxycycline Hyclate capsules USP, 50 mg and 100 mg, have an estimated market size of USD 80 million for twelve months ending December 2017, according to IQVIA,” Alembic Pharma said.

The company currently has a total of 73 ANDA approvals (65 final approvals and 8 tentative approvals) from USFDA, it added.

Shares of Alembic Pharmaceuticals today closed at Rs 506.55 per scrip on BSE, up 3.32 per cent from its previous close.

  • Related Posts

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Rajkot: The Narcotics Control Bureau (NCB) on Monday said it has secured a “major conviction” in the case of illegal diversion of medical drugs involving a Haryana-based company via Gujarat’s Pipavav…

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Thiruvanantpuram: The Ethics Committee of the Council of Indian Systems of Medicine, Kerala State Medical Councils, has imposed a fine of ₹50,000 on a registered Ayurveda practitioner for advertising his…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Pharma company, its employees convicted for ‘illegal diversion” of meth precursor abroad

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Ayurveda practitioner fined by ISM Council for violation of professional ethics

    Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

    Administering rabies vaccine at the wrong site can be fatal: Shoulders or thighs only, warn experts

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    Delhi HC allows Zydus to sell biosimilar of blockbuster anti-cancer drug Nivolumab

    DoP may exempt 11 more drugs from public procurement rules

    DoP may exempt 11 more drugs from public procurement rules

    DoP calls for proposals to set up common facilities for medical device clusters

    DoP calls for proposals to set up common facilities for medical device clusters